Molecular Stratification of Multiple Sclerosis and Associated Neuro-autoimmune Di
Molecular Stratification of Multiple Sclerosis and Associated Neuro-autoimmune Di
批准号:
8726564
负责人:
Robert C Axtell
金额:
$24.9万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-15 至 2016-08-31
关键词:
Adoptive TransferAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAreaAttenuatedAutoimmune ProcessAutoimmunityBiologicalBiological MarkersBlocking AntibodiesBloodBlood TestsCD4 Positive T LymphocytesCell Culture TechniquesCellsCellular biologyCerebrospinal FluidClinical ResearchCytokine Network PathwayDataDevelopmentDisciplineDiseaseEmployee StrikesEnsureEnvironmentEventExperimental Autoimmune EncephalomyelitisFacultyGoalsHumanImmuneIn VitroInflammationInflammatoryInterferon-betaInterferonsInterleukin-10Knockout MiceLinkLongitudinal StudiesMentorsMolecularMultiple SclerosisMusOutcomePathway interactionsPatientsPharmaceutical PreparationsPlayPublishingRegulationRelapsing-Remitting Multiple SclerosisResearchResearch InstituteResearch PersonnelRoleSTAT1 geneSTAT4 geneScienceSerumSignal PathwaySignal TransductionStratificationTechniquesTherapeuticTissuesTrainingTranscriptional RegulationWorkabstractingactive methodcell typecohortcytokineeffective therapymeetingsmouse modelplanetary Atmosphereresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract:
Research Plan: Although Interferon-beta is one of the most popular treatments for multiple
sclerosis, its mode of action as a drug is still not fully understood. Moreover, IFN-beta therapy is
only partially effective and approximately 30% of MS patients do not respond to treatment. We
recently published that response to IFN-beta therapy is dictated by TH1 and TH17 pathways.
Using mouse models for MS, we found that IFN-beta attenuates TH1 induced disease but
exacerbates TH17 disease. In a small cohort of MS patients, we observed high serum levels of
IL-17F, a TH17 cytokine, in non-responders prior to the initiation of treatment. The goals of this
research are to:
1. Determine the mechanisms by which IFN-beta treatment exerts its pro- and anti- inflammatory
effects. This will be accomplished by using mouse models of MS and human CD4 T-cell
culturing experiments, described in Aim 1 and 3 respectively.
2. Identify biomarkers in MS blood and spinal fluid that predict and track the responsiveness to
IFN-¿ treatment. This will be accomplished by analyzing cytokine profiles in patient's blood and
spinal fluid in a longitudinal study, described in Aim 2.
Training: The research proposed in this application covers a wide range of experimental
techniques requiring expertise in animal models of autoimmunity, human immune cell biology,
cell signaling, transcriptional regulation and experimentation with disease tissue. Therefore,
additional training will be required in experimental techniques, statistical analysis, and
organization of clinical research. Dr. Steinman, my mentor, along with Dr. Dunn
(collaborator/consultant), and Dr. Racke (consultant) are experts in these areas and will ensure
that these training needs are met.
Environment: Stanford is a renowned academic research institute with a long record of
producing cutting edge science. Stanford has a highly collaborative atmosphere with state-of-
the-art facilities and world class investigators in many disciplines, many of whom are conducting
research that is complementary to the work proposed in this application.
The proposed research plan, training development and environment at Stanford will be highly
conducive for my transition to an independent faculty.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the roles type I Interferon and TH17 play in Neuromyelitis Optica and other autoimmune diseases.
-
批准号:10215451
-
项目类别:
-
资助金额:$70.08万
-
财政年份:2018
-
负责人:Robert C Axtell
-
依托单位:
Understanding the roles type I Interferon and TH17 play in Neuromyelitis Optica and other autoimmune diseases.
-
批准号:9751758
-
项目类别:
-
资助金额:$70.08万
-
财政年份:2018
-
负责人:Robert C Axtell
-
依托单位:
Pathogenic B cell and T helper cell interactions in Neuromyelitis Optica
-
批准号:10178030
-
项目类别:
-
资助金额:$42.32万
-
财政年份:2017
-
负责人:Robert C Axtell
-
依托单位:
Pathogenic B cell and T helper cell interactions in Neuromyelitis Optica
-
批准号:9216116
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2017
-
负责人:Robert C Axtell
-
依托单位:
Functional Interaction Between T-cell and B-cell Immune Pathways in Neuro- inflammatory Disorders
-
批准号:9332909
-
项目类别:
-
资助金额:$64.61万
-
财政年份:2016
-
负责人:Robert C Axtell
-
依托单位:
Molecular Stratification of Multiple Sclerosis and Associated Neuro-autoimmune Di
-
批准号:8734968
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2013
-
负责人:Robert C Axtell
-
依托单位:
Molecular Stratification of Multiple Sclerosis and Associated Neuro-autoimmune Di
-
批准号:8262668
-
项目类别:
-
资助金额:$8.93万
-
财政年份:2011
-
负责人:Robert C Axtell
-
依托单位:
Molecular Stratification of Multiple Sclerosis and Associated Neuro-autoimmune Di
-
批准号:8165160
-
项目类别:
-
资助金额:$8.96万
-
财政年份:2011
-
负责人:Robert C Axtell
-
依托单位:
海外基金